All sponsors

OncoC4, Inc.

Clinical trial pipeline · active industry-sponsored Phase 1/2 to Phase 3 trials · updated 2026-11-18
ACTIVE TRIALS6
PHASE 3 / 2-32
RECRUITING1
READOUTS ≤12 MONTHS4
READOUT SLIPPED >6 MO100%

Delay Index: of 5 active trials registered more than a year ago, 5 have moved their primary completion (readout) date by more than 6 months since first registration (median +14.0 months). See all sponsors →

Open OncoC4, Inc. on the live radar map →
TRIALPHASESTATUSCONDITIONNPRIMARY COMPLETION
PRESERVE-004
NCT05446298
P2Active, not recruitingOvarian Cancer; High Grade Serous Adenocarcinoma of Ovary582026-08-30 (+11 mo)
PRESERVE-006
NCT05682443
P1/2Active, not recruitingMetastatic Castration-resistant Prostate Cancer1482026-11-30 (+11 mo)
PRESERVE-001
NCT04140526
P1/2Active, not recruitingNon Small Cell Lung Cancer; Advanced Solid Tumor7332026-12-31 (+59 mo)
BiPAVE-001
NCT06635785
P1/2RecruitingAdvanced Solid Tumor3872027-06-30 (+18 mo)
PRESERVE-003
NCT05671510
P3Active, not recruitingNon Small Cell Lung Cancer6302027-08-31 (+14 mo)
Gotistobart
NCT07659379
P3Enrolling by invitationAdvanced Solid Tumor202036-07-01